Sofinnova Management X-A, L.L.C.
- SEC CIK
- 0001965187
No open-market purchases or sales filed in the past year.
Current role at each company
- CINC CinCor Pharma, Inc.10% Owneras of Feb 27, 2023
- VERA Vera Therapeutics, Inc.10% Owneras of Feb 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sofinnova Management X-A, L.L.C. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CINC CinCor Pharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2023 (view filing)9:15 PM ET | Nov 28, 2022 | 91 daysLate | Healy James and 4 othersDirector, 10% Owner | SSale | −6.00K | $14.32 | −$85.9K | −100.0%0 after |
VERA Vera Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 (view filing)6:29 PM ET | Feb 6 | 2 days | Katabi Maha and 4 othersDirector, 10% Owner | PPurchaseClass A Common Stock | +285.7K | $7.00 | +$2.00M | +9.0%3.47M after |